These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

600 related items for PubMed ID: 10362349

  • 1. Angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the treatment of heart failure caused by left ventricular systolic dysfunction.
    Sander GE, McKinnie JJ, Greenberg SS, Giles TD.
    Prog Cardiovasc Dis; 1999; 41(4):265-300. PubMed ID: 10362349
    [Abstract] [Full Text] [Related]

  • 2. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
    Makkar KM, Sanoski CA, Spinler SA.
    Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
    [Abstract] [Full Text] [Related]

  • 3. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 4. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

  • 5. [Blockade of the renin-angiotensin system by a combination of ACE inhibitors and AT1 receptor antagonists].
    Azizi M.
    Rev Prat; 2004 Jun 15; 54(11):1167-74. PubMed ID: 15496022
    [Abstract] [Full Text] [Related]

  • 6. Left ventricular diastolic heart failure with normal left ventricular systolic function in older persons.
    Aronow WS.
    J Lab Clin Med; 2001 May 15; 137(5):316-23. PubMed ID: 11329528
    [Abstract] [Full Text] [Related]

  • 7. [Pathophysiological and clinical implications of AT(1)/AT(2) angiotensin II receptors in heart failure and coronary and renal failure].
    Sandmann S, Unger T.
    Drugs; 2002 May 15; 62 Spec No 1():43-52. PubMed ID: 12036388
    [Abstract] [Full Text] [Related]

  • 8. Cardioprotection by aldosterone receptor antagonism in heart failure. Part I. The role of aldosterone in heart failure.
    Dieterich HA, Wendt C, Saborowski F.
    Fiziol Cheloveka; 2005 May 15; 31(6):97-105. PubMed ID: 16366159
    [Abstract] [Full Text] [Related]

  • 9. Angiotensin II type 1 receptor blockade: a novel therapeutic concept.
    Johnston CI.
    Blood Press Suppl; 2000 May 15; 1():9-13. PubMed ID: 11059629
    [Abstract] [Full Text] [Related]

  • 10. Cardioprotective effect of angiotensin II receptor antagonists.
    White M.
    Can J Cardiol; 1999 Nov 15; 15 Suppl F():10F-4F. PubMed ID: 10579747
    [Abstract] [Full Text] [Related]

  • 11. The therapeutic role of RAS blockade in chronic heart failure.
    Werner CM, Böhm M.
    Ther Adv Cardiovasc Dis; 2008 Jun 15; 2(3):167-77. PubMed ID: 19124420
    [Abstract] [Full Text] [Related]

  • 12. [The role of the selective blocking of angiotensin II receptors in the treatment of cardiovascular diseases].
    Carnovali M.
    Clin Ter; 2001 Jun 15; 152(2):103-6. PubMed ID: 11441521
    [Abstract] [Full Text] [Related]

  • 13. Should angiotensin receptor blockers be added to angiotensin-converting enzyme inhibitors in the treatment of heart failure?
    Ghanem FA, Movahed A.
    Rev Cardiovasc Med; 2005 Jun 15; 6(4):206-13. PubMed ID: 16379016
    [Abstract] [Full Text] [Related]

  • 14. Clinical studies on the therapy of heart failure using ACE-inhibitors and AT1-receptor blockers--does combination treatment make sense?
    Hennig L.
    Clin Nephrol; 2002 Jul 15; 58 Suppl 1():S7-11. PubMed ID: 12227730
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the effects of angiotensin receptor antagonist, angiotensin converting enzyme inhibitor, and their combination on regression of left ventricular hypertrophy of diabetes type 2 patients on recent onset hemodialysis therapy.
    Suzuki H, Kanno Y, Kaneko K, Kaneko M, Kotaki S, Mimura T, Takane H.
    Ther Apher Dial; 2004 Aug 15; 8(4):320-7. PubMed ID: 15274684
    [Abstract] [Full Text] [Related]

  • 16. Blockade of the renin-angiotensin system. Effect on mortality in patients with left ventricular systolic dysfunction.
    Pitt B.
    Cardiol Clin; 1994 Feb 15; 12(1):101-14. PubMed ID: 8181019
    [Abstract] [Full Text] [Related]

  • 17. Pharmacology of ACE inhibitors versus AT1 blockers.
    Vaughan D.
    Can J Cardiol; 2000 Aug 15; 16 Suppl E():36E-40E. PubMed ID: 10906625
    [Abstract] [Full Text] [Related]

  • 18. Angiotensin II receptors-antagonists, molecular biology, and signal transduction.
    Jagadeesh G.
    Indian J Exp Biol; 1998 Dec 15; 36(12):1171-94. PubMed ID: 10093499
    [Abstract] [Full Text] [Related]

  • 19. Angiotensin receptor antagonists and ACE inhibitors.
    Howes LG, Christie N.
    Aust Fam Physician; 1998 Oct 15; 27(10):914-7, 919-21. PubMed ID: 9798290
    [Abstract] [Full Text] [Related]

  • 20. Effect of chronic angiotensin II type I receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic variables in patients with heart failure.
    Davie AP, Rumley A, Lowe GD, McMurray JJ.
    Thromb Haemost; 2001 Dec 15; 86(6):1585-6. PubMed ID: 11776334
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.